(Q53368104)

English

The association between 3-hydroxy-3-methylglutaryl conenzyme A inhibitor use and breast carcinoma risk among postmenopausal women: a case-control study.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/15160333

The association between 3-hydroxy-3-methylglutaryl conenzyme A inhibitor use and breast carcinoma risk among postmenopausal women: a case-control study. (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/15160333

breast carcinoma

1 reference

based on heuristic

inferred from title

Susan R Heckbert

4

object named as

Susan R Heckbert

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/15160333

6

object named as

Janet R Daling

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/15160333

Kathleen E. Malone

3

object named as

Kathleen E Malone

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/15160333

Denise M Boudreau

1

object named as

Denise M Boudreau

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/15160333

Jacqueline S Gardner

2

object named as

Jacqueline S Gardner

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/15160333

author name string

David K Blough

5

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/15160333

language of work or name

0 references

publication date

1 June 2004

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/15160333

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/15160333

100

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/15160333

11

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/15160333

2308-2316

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/15160333

Carcinogenicity of lipid-lowering drugs

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20271

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of pravastatin on cardiovascular events in women after myocardial infarction: the cholesterol and recurrent events (CARE) trial.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20271

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20271

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20271

7 January 2021

based on heuristic

inferred from DOI database lookup

Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: findings from the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20271

7 January 2021

based on heuristic

inferred from DOI database lookup

3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and the risk of cancer: a nested case-control study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20271

7 January 2021

based on heuristic

inferred from DOI database lookup

Lipid-Lowering Medication and Risk of Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20271

7 January 2021

based on heuristic

inferred from DOI database lookup

Statin use and the risk of breast and prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20271

7 January 2021

based on heuristic

inferred from DOI database lookup

Statin use, hyperlipidaemia, and the risk of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20271

7 January 2021

based on heuristic

inferred from DOI database lookup

Statin use and the risk of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20271

7 January 2021

based on heuristic

inferred from DOI database lookup

Lipid-Lowering Drug Use and Breast Cancer in Older Women: A Prospective Study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20271

7 January 2021

based on heuristic

inferred from DOI database lookup

Lovastatin induces growth inhibition and apoptosis in human malignant glioma cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20271

7 January 2021

based on heuristic

inferred from DOI database lookup

Lovastatin inhibits proliferation and differentiation and causes apoptosis in lipopolysaccharide-stimulated murine B cells.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20271

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of the effect of the 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors simvastatin, lovastatin and pravastatin on leukaemic and normal bone marrow progenitors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20271

7 January 2021

based on heuristic

inferred from DOI database lookup

HMG-CoA reductase mediates the biological effects of retinoic acid on human neuroblastoma cells: lovastatin specifically targets P-glycoprotein-expressing cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20271

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibitory effect of simvastatin on the proliferation of human myeloid leukaemia cells in severe combined immunodeficient (SCID) mice

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20271

7 January 2021

based on heuristic

inferred from DOI database lookup

Lovastatin induced control of blast cell growth in an elderly patient with acute myeloblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20271

7 January 2021

based on heuristic

inferred from DOI database lookup

Blocking protein geranylgeranylation is essential for lovastatin-induced apoptosis of human acute myeloid leukemia cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20271

7 January 2021

based on heuristic

inferred from DOI database lookup

Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits the signaling pathways involved in the invasiveness and metastatic properties of highly invasive breast cancer cell lines: an in vitro study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20271

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction of mouse mammary tumor formation and metastasis by lovastatin, an inhibitor of the mevalonate pathway of cholesterol synthesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20271

7 January 2021

based on heuristic

inferred from DOI database lookup

Anti-carcinogenic activity of simvastatin during the promotion phase of radiation-induced mammary tumorigenesis of rats

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20271

7 January 2021

based on heuristic

inferred from DOI database lookup

HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20271

7 January 2021

based on heuristic

inferred from DOI database lookup

A validation study of patient interview data and pharmacy records for antihypertensive, statin, and antidepressant medication use among older women

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20271

7 January 2021

based on heuristic

inferred from DOI database lookup

Adherence with statin therapy in elderly patients with and without acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20271

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term persistence in use of statin therapy in elderly patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20271

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of socioeconomic status on drug selection for the elderly in Canada

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20271

7 January 2021

based on heuristic

inferred from DOI database lookup

Breast cancer risk in relation to serum cholesterol, serum beta-lipoprotein, height, weight, and blood pressure.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20271

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of breast cancer in relation to blood lipids: a prospective study of 31,209 Norwegian women

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20271

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum cholesterol and risk of cancer in a cohort of 39,000 men and women

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20271

7 January 2021

based on heuristic

inferred from DOI database lookup

Do statins cause cancer? A meta-analysis of large randomized clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20271

7 January 2021

based on heuristic

inferred from DOI database lookup

Should there be a moratorium on the use of cholesterol lowering drugs?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20271

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20271

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase I-II trial of lovastatin for anaplastic astrocytoma and glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20271

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of high-dose lovastatin in patients with advanced gastric adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20271

7 January 2021

based on heuristic

inferred from DOI database lookup

The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20271

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of endothelial cell migration by cerivastatin, an HMG-CoA reductase inhibitor: contribution to its anti-angiogenic effect

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20271

7 January 2021

based on heuristic

inferred from DOI database lookup

Lovastatin and tumor necrosis factor-alpha exhibit potentiated antitumor effects against Ha-ras-transformed murine tumor via inhibition of tumor-induced angiogenesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20271

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular multitasking: statins lead to more arteries, less plaque

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20271

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20271

7 January 2021

based on heuristic

inferred from DOI database lookup

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20271

7 January 2021

based on heuristic

inferred from DOI database lookup

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20271

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.20271

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/15160333

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/15160333

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53368104&oldid=1746187968"